Pioneering surgical training technology businesses Inovus Medical and UpSurgeOn have announced a global strategic partnership.
The move stands to enhance access to high quality surgical training for thousands of surgeons across the globe.
A centrepiece of the partnership is the integration of UpSurgeOn’s full portfolio of mixed reality surgical simulation technologies into Inovus Medical’s Totum digital surgery platform.
The integration will create a world-first ‘digital synthetic cadaver’ for cranial, spine, ENT, and plastic surgery, combining UpSurgeOn’s life-like anatomical and tissue simulation with the digital capabilities of Totum.
Inovus Medical will also serve as the commercial partner to UpSurgeOn in several key international territories.
“I have been a huge fan of the UpSurgeOn team and products for many years,” said Dr Elliot Street, CEO of Inovus Medical.
“The quality and realism of their simulators is unmatched, and by integrating UpSurgeOn’s expertise in cranial, spine, ENT, and plastic surgery simulation with the Totum platform, we are not only enhancing the offering of both companies, but creating a revolutionary digital synthetic cadaver.
“This world-first innovation represents the future of surgical education – immersive, scalable, and accessible on a global scale, and I am excited to see the positive impact this has on the growth of both businesses.”
Dr Federico Nicolosi, CEO of UpSurgeOn, added: “Inovus has revolutionised the disciplines it operates in, and I have been profoundly inspired by the way they’ve achieved this in General Surgery and Gynecology.
“As a neurosurgeon, during my training, I often envied the immense opportunities my colleagues in those fields had, thanks to the genius of the Inovus team and the unparalleled level of their mixed reality technologies.
“They have created a new paradigm in these disciplines. Joining forces will have an unprecedented global impact, showcasing to the world that the future of healthcare is deeply rooted in advanced surgical simulation – reducing risks for patients and costs for healthcare institutions, MedTech companies, and insurance providers.”
Inovus Medical receives £1m as part of LCR Innovation Zone Programme